Diabetes mellitus (DM) is a complicated metabolic illness that has had a worldwide impact and placed an unsustainable load on both developed and developing countries’ health care systems. According to the International Diabetes Federation, roughly 537 million individuals had diabetes in 2021, with type 2 diabetes mellitus accounting for the majority of cases (T2DM). T2DM is a chronic illness defined by insufficient insulin production from pancreatic islet cells. T2DM generates various micro and macrovascular problems, with diabetic nephropathy (DN) being one of the most serious microvascular consequences, and which can lead to end-stage renal disease. The zebrafish (Danio rerio) has set the way for its future as a disease model organism. As numerous essential developmental processes, such as glucose metabolism and reactive metabolite production pathways, have been identified in zebrafish that are comparable to those seen in humans, it is a good model for studying diabetes and its consequences. It also has many benefits over other vertebrate models, including the permeability of its embryos to small compounds, disease-driven therapeutic target selection, in vivo validation, and deconstruction of biological networks. The organism can also be utilized to investigate and understand the genetic abnormalities linked to the onset of diabetes problems. Zebrafish may be used to examine and visualize the growth, morphology, and function of organs under normal physiological and diabetic settings. The zebrafish has become one of the most useful models for studying DN, especially when combined with genetic alterations and/or mutant or transgenic fish lines. The significant advancements of CRISPR and next-generation sequencing technology for disease modelling in zebrafish, as well as developments in molecular and nano technologies, have advanced the understanding of the molecular mechanisms of several human diseases, including DN. In this review, we emphasize the physiological and pathological processes relating to microvascular problems in zebrafish, as well as the many experimental zebrafish models used to research DN, and the DN-related outcomes and mechanisms observed in zebrafish.
Introduction. Nematode Caenorhabditis elegans is a key model for studying host–pathogen interactions. In our study, we explored the impact of extended-spectrum beta-lactamase (ESBL) and metallo-beta-lactamase (MBL) producing strains of Pseudomonas aeruginosa on C. elegans, examining survival, reproductive fitness, chemotaxis behaviour, and gene expression. Both ESBL and MBL-producing P. aeruginosa showed a slow killing phenotype in C. elegans, with prolonged gut colonization and reduced lifespan compared to worms fed Escherichia coli OP50. Materials and methods. C. elegans N2 strain was exposed to ESBL/MBL-producing P. aeruginosa strains, non-resistant P. aeruginosa, and E. coli OP50. Survival, reproductive fitness, chemotaxis, and gene expression of daf-16 and age-1 were analyzed via assays and qRT-PCR. Results. Resistant strains caused accelerated mortality, starting on day 2, while non-resistant strains had delayed mortality from day 5. This indicates that ESBL and MBL enzymes may boost P. aeruginosa's virulence. Worms exposed to these resistant strains had reduced fecundity, showing impaired reproductive fitness. Changes in chemotaxis behaviour suggested that virulence factors and quorum sensing might affect how worms seek food. Gene expression analysis revealed significant changes in daf-16, a gene involved in stress resistance and immunity, in response to ESBL and MBL strains. However, there were no significant differences in the expression of age-1, indicating other mechanisms at play besides insulin/insulin-like growth factor signalling. Conclusion. This study highlights the complex interactions between bacterial virulence, host survival, and reproductive behaviour. By exploring the effects of antibiotic resistance on C. elegans, we offer insights into the broader implications of antibiotic-resistant infections and potential strategies for managing them.
Corbichonia decumbens is a medicinal plant with limited comprehensive scientific investigation reported to date. The present study evaluated the phytochemical constituents and multifunctional activities of aqueous extract of C. decumbens leaves. In vitro antioxidant scavenging activity was analyzed using DPPH, H2O2, ABTS radical scavenging assays, while anti-inflammatory potential was evaluated by nitric oxide (NO) inhibition assay in RAW 264.7 cell lines, and antidiabetic activity assessed using the dinitrosalicylic acid (DNS) method. In our present study, the aqueous extract of C. decumbens leaves showed significant results in all radical scavenging assays, DPPH (IC50 - 75.38 ± 3.46 μg/mL), H2O2, (IC50 - 82.79 ± 2.24 μg/mL), ABTS (IC50 - 85.07 ± 2.27 μg/mL), NO inhibition (IC50 - 98.42 ± 1.71 μg/mL), and DNS (IC50 - 102.98 ± 3.95 μg/mL) against the control. The MTT assay was employed to study the cytotoxic properties of the extract, in breast cancer cell line (MCF-7), which demonstrated dose and time-dependent cell depletion with an IC50 value of 91.75 ± 0.89 μg/mL and an IC90 value of 209.99 ± 2.30 μg/mL, respectively. The extract revealed multi-target antimicrobial efficacy against eight bacterial and two fungal strains, along with promising antithrombotic potential and the presence of diverse therapeutically bioactive phytochemical constituents.